Follicular lymphoma lacking the t(14;18)(q32;q21): Identification of two disease subtypes

British Journal of Haematology

Volumn 120, Issue 3, 2003, Pages 424-433

  Horsman, Douglas E ^a,c   Okamoto, Ichiro ^a   Ludkovski, Olga ^a   Le, Nhu ^a   Harder, Lana ^b   Gesk, Stefan ^b   Siebert, Reiner ^b   Chhanabhai, Mukesh ^a   Sehn, Laurie ^a   Connors, Joseph M ^a   Gascoyne, Randy D ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

BCL2; BCL6; Follicular lymphoma; t(14; 18); t(3; 14)

Indexed keywords

HYBRID PROTEIN; PROTEIN BCL 2; PROTEIN BCL 6;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER CLASSIFICATION; CANCER RECURRENCE; CHROMOSOME 18; CHROMOSOME TRANSLOCATION 14; CHROMOSOME TRANSLOCATION 18; CLINICAL ARTICLE; COHORT ANALYSIS; DIAGNOSTIC VALUE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLICULAR LYMPHOMA; GENE DELETION; GENE DUPLICATION; GENE FREQUENCY; GENE OVEREXPRESSION; GENE REARRANGEMENT; GENETIC ANALYSIS; GROWTH REGULATION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; KARYOTYPE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 18; CHROMOSOMES, HUMAN, PAIR 3; FEMALE; HUMANS; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LYMPHOMA, FOLLICULAR; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-BCL-2; TRANSLOCATION, GENETIC;

EID: 0037326442     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2003.04086.x     Document Type: Article

References (47)

1. Bastion, Y., Sebban, C., Berger, F., Felman, P., Salles, G., Dumontet, C., Bryon, P.A. & Coiffier, B. (1997) Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma cases. Journal of Clinical Oncology, 15, 1587-1594.
2. Biagi, J.J. & Seymour, J.F. (2002) Insights into the molecular pathogenesis of follicular lymphoma arising from analysis of geographic variation. Blood, 99, 4265-4275.
3. Chaganti, S.R., Chen, W., Parsa, N., Offit, K., Louie, D.C., Dalla-Favera, R. & Chaganti, R.S. (1998) Involvement of BCL6 in chromosomal aberrations affecting band 3q27 in B-cell non-Hodgkin lymphoma. Genes, Chromosomes and Cancer, 23, 323-327.
4. Gascoyne, R.D., Argatoff, L., James, G., Klasa, R., Wilson, K., Connors, J.M. & Horsman, D.E. (1997a) The prognostic significance of cytogenetic abnormalities in follicular lymphomas (FL). Modern Pathology, 10, 126a.
5. Gascoyne, R.D., Adomat, S.A., Krajewski, S., Krajewska, M., Horsman, D.E., Tolcher, A.W., O'Reilly, S.E., Hoskins, P., Coldman, A.J., Reed, J.C. & Connors, J.M. (1997b) Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma. Blood, 90, 244-251.
6. Gaulard, P., d'Agay, M.F., Peuchmaur, M., Brousse, N., Gisselbrecht, C., Solal-Celigny, P., Diebold, J. & Mason, D.Y. (1992) Expression of the bcl-2 gene product in follicular lymphoma. American Journal of Pathology, 140, 1089-1095.
7. Gelb, A.B., Rouse, R.V., Dorfman, R.F. & Warnke, R.A. (1994) Detection of immunophenotypic abnormalities in paraffin-embedded B-lineage non-Hodgkin's lymphomas. American Journal of Clinical Pathology, 102, 825-834.
8. Gesk, S., Harder, L., Grote, W., Schlegelberger, B. & Siebert, R. (2001) Evaluation of the commercially available interphase FISH probe LSI IGH/CCND1 and LSI IGH/BCL2 for the detection of t(11;14) and t(14;18) in malignant lymphomas. Annals of Hematology, 80, B137-132.
9. Harris, N.L., Jaffe, E.S., Diebold, J., Flandrin, G., Muller-Hermelink, H.K., Vardiman, J., Lister, T.A. & Bloomfield, C.D. (1999) World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November 1997. Journal of Clinical Oncology, 17, 3835-3849.
10. Harris, N.L., Jaffe, E.S., Diebold, J., Flandrin, G., Muller-Hermelink, H.K., Vardiman, J., Lister, T.A. & Bloomfield, C.D. (2000) The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Histopathology, 36, 69-86.
11. Hockenbery, D., Nunez, G., Milliman, C., Schreiber, R.D. & Korsmeyer, S.J. (1990) Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature, 348, 334-336.
12. Hoglund, M., Gisselsson, D., Mandahl, N., Johansson, B., Mertens, F., Mitelman, F. & Sall, T. (2001) Multivariate analyses of genomic imbalances in solid tumors reveal distinct and converging pathways of karyotypic evolution. Genes, Chromosomes and Cancer, 31, 156-171.
13. Horsman, D.E., Gascoyne, R.D., Coupland, R.W., Coldman, A.J. & Adomat, S.A. (1995) Comparison of cytogenetic analysis, southern analysis, and polymerase chain reaction for the detection of t(14;18) in follicular lymphoma. American Journal of Clinical Pathology, 103, 472-478.
14. Horsman, D.E., Connors, J.M., Pantzar, T. & Gascoyne, R.D. (2001) Analysis of secondary chromosomal alterations in 165 cases of follicular lymphoma with t(14;18). Genes, Chromosomes and Cancer, 30, 375-382.
15. ISCN (1995) International System for Cytogenetic Nomenclature, Karger, Basil.
16. Johansson, B., Mertens, F. & Mitelman, F. (1995) Cytogenetic evolution patterns in non-Hodgkin's lymphoma. Blood, 86, 3905-3914.
17. Katzenberger, T., Lohr, A., Ott, M.M., Kalla, J., Rosenwald, A., Muller-Hermelink, H.K. & Ott, G. (2000) Genetic and biological features define two types of follicular non-Hodgkin grade 3 lymphoma. Verhandlungen der Deutschen Gesellschaft fur Pathologie, 84, 153-161.
18. Knutsen, T. (1997) Cytogenetic mechanisms in the pathogenesis and progression of follicular lymphoma. Cancer Surveys, 30, 163-192.
19. Kramer, M.H., Hermans, J., Wijburg, E., Philippo, K., Geelen, E., van Krieken, J.H., de Jong, D., Maartense, E., Schuuring, E. & Kluin, P.M. (1998) Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma. Blood, 92, 3152-3162.
20. Kristoffersson, U., Heim, S., Olsson, H., Akerman, M. & Mitelman, F. (1986) Cytogenetic studies in non-Hodgkin lymphomas: results from surgical biopsies. Hereditas, 104, 1-13.
21. Kurland, J.F., Kodym, R., Story, M.D., Spurgers, K.B., McDonnell, T.J. & Meyn, R.E. (2001) NF-kappaB1 (p50) homodimers contribute to transcription of the bcl-2 oncogene. Journal of Biological Chemistry, 276, 45380-45386.
22. Lai, R., Arber, D.A., Chang, K.L., Wilson, C.S. & Weiss, L.M. (1998) Frequency of bcl-2 expression in non-Hodgkin's lymphoma: a study of 778 cases with comparison of marginal zone lymphoma and monocytoid B-cell hyperplasia. Modern Pathology, 11, 864-869.
23. Lestou, V.S., Gascoyne, R.D., Salski, C., Connors, J.M. & Horsman, D.E. (2002) Uncovering novel inter- and intrachromosomal chromosome 1 aberrations in follicular lymphomas by using an innovative multicolor banding technique. Genes, Chromosomes and Cancer, 34, 201-210.
24. Levine, E.G., Juneja, S., Arthur, D., Garson, O.M., Machnicki, J.L., Frizzera, G., Ironside, P., Cooper, I., Hurd, D.D., Peterson, B.A., Mosel, D. & Bloomfield, C.D. (1990) Sequential karyotypes in non-Hodgkin lymphoma: their nature and significance. Genes, Chromosomes and Cancer, 1, 270-280.
25. Lopez-Guillermo, A., Cabanillas, F., McDonnell, T.I., McLaughlin, P., Smith, T., Pugh, W., Hagemeister, F., Rodriguez, M.A., Romaguera, J.E., Younes, A., Sarris, A.H., Preti, H.A. & Lee, M.S. (1999) Correlation of bcl-2 rearrangement with clinical characteristics and outcome in indolent follicular lymphoma. Blood, 93, 3081-3087.
26. Louie, D.C., Hochauser, D., Schluger, A., Jaslow, R., Roy, P., Oliver, J., Offit, K. & Chagnati, R.S.K. (1996) BCL6 and BCL2 rearrangement and p53 over-expression as prognostic factors in follicular lymphoma. Annals of Oncology, 7, 16.
27. McDonnell, T.J. & Korsmeyer, S.J. (1991) Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18). Nature, 349, 254-256.
28. Mann, R.B. & Berard, C.W. (1983) Criteria for the cytologic sub-classification of follicular lymphomas: a proposed alternative method. Hematological Oncology, 1, 187-192.
29. Martin, A.R., Weisenburger, D.D., Chan, W.C., Ruby, E.I., Anderson, J.R., Vose, J.M., Bierman, P.J., Bast, M.A., Daley, D.T. & Armitage, J.O. (1995) Prognostic value of cellular proliferation and histologic grade in follicular lymphoma. Blood, 85, 3671-3678.
30. Nguyen, P.L., Zukerberg, L.R., Benedict, W.F. & Harris, N.L. (1996) Immunohistochemical detection of p53, bcl-2, and retino-blastoma proteins in follicular lymphoma. American Journal of Clinical Pathology, 105, 538-543.
31. Papakonstantinou, G., Verbeke, C., Hastka, J., Bohrer, M. & Hehlmann, R. (2001) bcl-2 expression in non-Hodgkin's lymphomas is not associated with bcl-2 gene rearrangements. British Journal of Haematology, 113, 383-390.
32. Pezzella, F., Ralfkiaer, E., Gatter, K.C. & Mason, D.Y. (1990) The 14;18 translocation in European cases of follicular lymphoma: comparison of Southern blotting and the polymerase chain reaction. British Journal of Haematology, 76, 58-64.
33. Pezzella, F., Jones, M., Ralfkiaer, E., Ersboll, J., Gatter, K.C. & Mason, D.Y. (1992) Evaluation of bcl-2 protein expression and 14;18 translocation as prognostic markers in follicular lymphoma. British Journal of Cancer, 65, 87-89.
34. Sanger, W.G., Armitage, J.O., Bridge, J., Weisenburger, D.D., Fordyce, R. & Purtilo, D.T. (1987) Initial and subsequent cytogenetic studies in malignant lymphoma. Cancer, 60, 3014-3019.
35. Schlegelberger, B., Zwingers, T., Harder, L., Nowotny, H., Siebert, R., Vesely, M., Bartels, H., Sonnen, R., Hopfinger, G., Nader, A., Ott, G., Muller-Hermelink, K., Feller, A. & Heinz, R. (1999a) Clinicopathogenetic significance of chromosomal abnormalities in cases with blastic peripheral B-cell lymphoma, Kiel-Wien-Lymphoma Study Group. Blood, 94, 3114-3120.
36. Schlegelberger, B., Metzke, S., Harder, S., Zuhlke-Jenisch, R., Zhang, Y. & Siebert, R. (1999b) Diagnostic Cytogenetics. Springer-Verlag, Berlin.
37. Sehn, L., Gascoyne, R.D., Connors, J.M., Klasa, R.J. & Horsman, D.E. (2000) Comparison of t(14;18) positive and t(14;18) negative follicular lymphoma (FL): clinical characteristics, outcome and cytogenetics. Blood, 96, 574a.
38. Simonian, P.L., Grillot, D.A. & Nunez, G. (1997) Bcl-2 and Bcl-XL can differentially block chemotherapy-induced cell death. Blood, 90, 1208-1216.
39. Skinnider, B.F., Horsman, D.E., Dupuis, B. & Gascoyne, R.D. (1999) Bcl-6 and Bcl-2 protein expression in diffuse large B-cell lymphoma and follicular lymphoma: correlation with 3q27 and 18q21 chromosomal abnormalities. Human Pathology, 30, 803-808.
40. The Non-Hodgkin's Lymphoma Classification Project (1997) A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood, 89, 3909-3918.
41. Tilly, H., Rossi, A., Stamatoullas, A., Lenormand, B., Bigorgne, C., Kunlin, A., Monconduit, M. & Bastard, C. (1994) Prognostic value of chromosomal abnormalities in follicular lymphoma. Blood, 84, 1043-1049.
42. Vaandrager, J.W., Schuuring, E., Raap, T., Philippo, K., Kleiverda, K. & Kluin, P. (2000) Interphase FISH detection of BCL2 rearrangement in follicular lymphoma using breakpoint-flanking probes. Genes, Chromosomes and Cancer, 27, 85-94.
43. Weisenburger, D.D., Gascoyne, R.D., Bierman, P.J., Shenkier, T., Horsman, D.E., Lynch, J.C., Chan, W.C., Greiner, T.C., Connors, J.M., Vose, J.M., Armitage, J.O. & Sanger, W.G. (2000) Clinical significance of the t(14;18) and BCL2 overexpression in follicular large cell lymphoma. Leukaemia and Lymphoma, 36, 513-523.
44. Wendum, D., Sebban, C., Gaulard, P., Coiffier, B., Tilly, H., Cazals, D., Boehn, A., Casasnovas, R.O., Bouabdallah, R., Jaubert, J., Ferrant, A., Diebold, J., de Mascarel, A. & Gisselbrecht, C. (1997) Follicular large-cell lymphoma treated with intensive chemotherapy: an analysis of 89 cases included in the LNH87 trial and comparison with the outcome of diffuse large B-cell lymphoma. Groupe d'Etude des Lymphomes de l'Adulte. Journal of Clinical Oncology, 15, 1654-1663.
45. Whang-Peng, J., Knutsen, T., Jaffe, E.S., Steinberg, S.M., Raffeld, M., Zhao, W.P., Duffey, P., Condron, K., Yano, T. & Longo, D.L. (1995) Sequential analysis of 43 cases with non-Hodgkin's lymphoma: clinical correlations with cytogenetic, histologic, immunophenotyping, and molecular studies. Blood, 85, 203-216.
46. Zelenetz, A.D., Chu, G., Galili, N., Bangs, C.D., Horning, S.J., Donlon, T.A., Cleary, M.L. & Levy, R. (1991) Enhanced detection of the t(14;18) translocation in malignant lymphoma using pulsed-field gel electrophoresis. Blood, 78, 1552-1560.
47. Zhou, P., Qian, L., Kozopas, K.M. & Craig, R.W. (1997) Mcl-1, a Bcl-2 family member, delays the death of hematopoietic cells under a variety of apoptosis-inducing conditions. Blood, 89, 630-643.